Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UBS Upgrades Eli Lilly to Buy, Announces $363 Price Target

UBS Upgrades Eli Lilly to Buy, Announces $363 Price Target

UBS analyst Navin Jacob upgrades Eli Lilly (NYSE:LLY) from Neutral to Buy and announces $363 price target.

September 22, 2022

1 minute read

UBS analyst Navin Jacob upgrades Eli Lilly (NYSE:LLY) from Neutral to Buy and announces $363 price target.

Celebrities, Joe Biden, Congress React To Hollywood’s Double Strike: ‘The Industry Is Very Profitable And You Should Share In Those Profits’

July 15, 11:55 AM

For the first time in decades, actors and writers are both striking in a move that could have a lasting impact on the movie and television industry.

November 16, 4:53 PM

Following the collapse of a major deal, Embracer Group (OTC: THQQF) has confirmed laying off 904 employees, constituting 5% of its workf

December 6, 12:53 PM

The oil and gas production sector has already seen some mega deals in 2023; M&A activity is expected to continue into 2024.

August 22, 11:00 AM

Over the past 3 months, 7 analysts have published their opinion on Genpact (NYSE:G) stock. These analysts are…